Elena Luganovski

Elena Luganovski is an accomplished executive in the field of biopharmaceuticals, currently serving as the Executive Director of CMC Strategy and Regulatory CMC at Ichnos Sciences since March 2020. Previously, Elena held key positions at Asana BioSciences as Director of CMC Biologics Lead, and at Immunomedics as Director of CMC Strategy, where significant contributions included overseeing the submission of critical regulatory documents and leading the preparation of responses for FDA inquiries. Earlier experience includes strategic CMC roles at Advanced Accelerator Applications and Daiichi Sankyo, along with a strong foundation in vaccine research and quality control from positions at Elusys Therapeutics and Roche Molecular Systems. Elena's educational background includes a Master’s degree in Biology/Immunology from Columbia University and further studies at New York University.